Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5138 participants.
Also called NCT06853535
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 5,138 participants
- Registry
-
NCT06853535
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06853535. Randomized; no masking; primary purpose prevention. Start 2025-05-23 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
- Acronym
- PATH STROKE C
- Condition
- Acute Ischemic Stroke
- Condition
- Clopidogrel Resistance
- Intervention (Drug)
- The ticagrelor
- Intervention (Drug)
- The Clopidogrel
- Lead sponsor
- Sichuan Provincial People's Hospital
- Collaborator
- Fudan University
- Collaborator
- Chengdu Medical College
Record details
- Record id
cardio:ct-nct06853535- Content hash
74616b1265d7be4afa0ff7851297eeb52001bd97d2832c808fe60a33c3cba862